Clinical Edge Journal Scan

Cognitive dysfunction predicts poor prognosis and mortality in multiple sclerosis


 

Key clinical point: Cognitive dysfunction in patients with multiple sclerosis (MS) is predictive of a higher risk for conversion from relapse-remitting MS to secondary progressive MS and a higher risk for death.

Major finding: Cognitive dysfunction was linked to a greater risk of converting from relapse-remitting course to progressive disease course (adjusted odds ratio, 2.29; P = .043) and shorter survival (adjusted hazard ratio, 3.07; P = .006).

Study details: This was a retrospective analysis of 408 patients with MS.

Disclosures: No external funding was received for this study. The authors reported no conflict of interests.

Source: Cavaco S et al. Mult Scler. 2021 Dec 30. doi: 10.1177/13524585211066598 .

Recommended Reading

Cannabis use common for MS-related spasticity
ICYMI Multiple Sclerosis
Specialty pharmacists may speed time to MS treatment
ICYMI Multiple Sclerosis
Brief, automated cognitive test may offer key advantages in MS
ICYMI Multiple Sclerosis
B-cell repletion is common with MS drug, but no symptom worsening
ICYMI Multiple Sclerosis
COVID-19 vaccination safe and effective in patients with multiple sclerosis
ICYMI Multiple Sclerosis
Risk factors for disease reactivation after natalizumab cessation in multiple sclerosis
ICYMI Multiple Sclerosis
Multiple sclerosis: Interferon therapy boosts humoral response following SARS-CoV-2 vaccination
ICYMI Multiple Sclerosis
Multiple sclerosis: Cognitive impairment worsens during the pre- and postrelapse period
ICYMI Multiple Sclerosis
Patients with multiple sclerosis at higher risk for cancer than general population
ICYMI Multiple Sclerosis
Increased sun and UVR exposure protective against developing pediatric MS
ICYMI Multiple Sclerosis